stage iii renal cell cancer
Showing 1 - 25 of 29
Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin
Completed
- Stage I Renal Cell Cancer
- +3 more
- Arterial Spin Labeling Magnetic Resonance Imaging
- +3 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 14, 2022
Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,
Recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- Pembrolizumab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 5, 2022
Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial (tivozanib, therapeutic conventional surgery)
Withdrawn
- Stage II Renal Cell Cancer
- Stage III Renal Cell Cancer
- tivozanib
- therapeutic conventional surgery
- (no location specified)
Aug 11, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Infiltrating Bladder Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage I Prostate Cancer Trial in Los Angeles (other,
Terminated
- Infiltrating Bladder Urothelial Carcinoma
- +9 more
- Cytology Specimen Collection Procedure
- +4 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 15, 2021
Myeloid Derived Suppressor Cells Clinical Assay in Finding
Recruiting
- Healthy Subject
- +5 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 16, 2021
Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Bronx, New York (vorinostat,
Terminated
- Recurrent Renal Cell Cancer
- +2 more
-
Bronx, New York
- +1 more
Feb 1, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +44 more
- fludarabine phosphate
- +9 more
-
Duarte, California
- +6 more
Sep 6, 2019
Magnetic Resonance Imaging in Predicting Response to Sunitinib
Completed
- Renal Cell Carcinoma
- +2 more
- mutation analysis
- +5 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Jun 21, 2019
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib
Completed
- Recurrent Renal Cell Carcinoma
- +4 more
- Erlotinib Hydrochloride
- +2 more
-
Tucson, Arizona
- +213 more
Dec 12, 2018
B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)
Completed
- B-Cell Neoplasm
- +15 more
-
Stanford, CaliforniaStanford University Medical Center
Dec 11, 2018
Renal Cancer Patients Treated by Non-IV Drugs
Unknown status
- Metastatic Renal Cancer
- Stage III Renal Cell Cancer
- observance of oral drug treatment
-
Angers, France
- +13 more
Oct 11, 2018
Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer Trial in Cleveland, Philadelphia
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- pazopanib hydrochloride
- therapeutic conventional surgery
-
Cleveland, Ohio
- +1 more
Aug 17, 2018
Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected
Completed
- Recurrent Melanoma
- +11 more
- siRNA-transfected peripheral blood mononuclear cells APN401
- laboratory biomarker analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018
Adult Solid Tumor, Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma Trial in Madison (Computed Tomography,
Completed
- Adult Solid Neoplasm
- +4 more
- Computed Tomography
- +5 more
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Oct 9, 2017
Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma, Recurrent Non-Small Cell Lung Carcinoma Trial in
Completed
- Head and Neck Squamous Cell Carcinoma
- +13 more
- Laboratory Biomarker Analysis
- +2 more
-
Palo Alto, California
- +4 more
Sep 14, 2017
Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,
Completed
- Childhood Renal Cell Carcinoma
- +12 more
- Doxorubicin Hydrochloride
- +9 more
-
Birmingham, Alabama
- +186 more
Jun 22, 2017
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Baltimore, Salisbury, Madison
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
-
Baltimore, Maryland
- +2 more
Dec 10, 2015
Adult Solid Tumor, Lung Carcinoid Tumor, Recurrent Digestive System Neuroendocrine Tumor G1 Trial in Vancouver, Hamilton,
Completed
- Adult Solid Neoplasm
- +10 more
- Laboratory Biomarker Analysis
- +3 more
-
Vancouver, British Columbia, Canada
- +2 more
Oct 5, 2015
Recurrent Renal Cell Cancer, Renal Cell Carcinoma, Stage III Renal Cell Cancer Trial in United States (etaracizumab,
Terminated
- Recurrent Renal Cell Cancer
- +3 more
- etaracizumab
- bevacizumab
-
Marysville, California
- +4 more
Apr 28, 2014
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer Trial in Baltimore, Madison (drug,
Completed
- Clear Cell Renal Cell Carcinoma
- +6 more
- sunitinib malate
- +6 more
-
Baltimore, Maryland
- +1 more
Apr 1, 2014
Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Recurrent Renal Cell Cancer Trial in Durham (drug, biological,
Terminated
- Clear Cell Renal Cell Carcinoma
- +4 more
- sorafenib tosylate
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jul 1, 2013
Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Chicago (ispinesib)
Completed
- Recurrent Renal Cell Cancer
- +2 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jun 4, 2013
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Chicago (ixabepilone,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- ixabepilone
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Mar 22, 2013